MacroGenics Inc

MGNXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$3.89

Today

-7.8%

YTD

+143.1%

About

MacroGenics Inc. is a clinical-stage biotechnology company that develops and commercialises innovative antibody-based therapies for cancer and other diseases. Its operations are conducted on an international scale, with a global reach in various markets. MacroGenics is part of the biopharmaceutical sector. Its technology platforms and expertise in protein engineering have enabled it to create several vital product candidates. It has also entered into strategic collaborations with global pharmaceutical and biotechnology companies. Monitor the MGNX share price by adding it to your eToro watchlist.

Price chart

Closing price history for MGNX (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-3.90

P/S (TTM)1.75

P/B (TTM)12.98

Market cap$275.23M

Cap tierMicro-cap

Industry avg P/E-43.30

Profitability

Gross margin69.93%

EBIT margin-40.53%

Net margin-177.01%

ROE-140.27%

ROA-31.80%

Earnings & Revenue

Revenue (TTM)$157.08M

Revenue growth (1Y)+2.0%

EPS (TTM)-$1.11

Free cash flow$-71.69M

Total debt$105.22M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.40

Employees293

Next earnings12 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.